Cost-Effectiveness Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Program for the Elderly Aged 60 Years or Older in Shanghai, China

Background: The pneumococcal vaccine has been considered as the most effective measure to prevent pneumococcal diseases. In 2013, Shanghai launched a major public health program to vaccinate people aged 60 years or older with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV-23) free of charge. By...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaodong, Tang, Yuekun, Ma, Xiaoying, Guo, Xiang, Huang, Zhuoying, Ren, Jia, Qiu, Jing, Jiang, Hongli, Lu, Yihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181136/
https://www.ncbi.nlm.nih.gov/pubmed/34109145
http://dx.doi.org/10.3389/fpubh.2021.647725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181136/
https://www.ncbi.nlm.nih.gov/pubmed/34109145
http://dx.doi.org/10.3389/fpubh.2021.647725

Ejemplares similares